Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials-Reference-Cited by-同舟云学术

Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials

Published:2020-05-15 Issue:8 Volume:34 Page:1744-1749
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Puig L.¹^ORCID,Tsai T.‐F.²,Bhutani T.³,Uy J.⁴,Ramachandran P.⁵,Song M.⁵,You Y.⁵,Gooderham M.⁶,Lebwohl M.⁷

Affiliation:

1. Hospital de la Santa Creu i Sant Pau Barcelona Spain

2. National Taiwan University Hospital Taipei Taiwan

3. University of California San Francisco Medical Center San Francisco CA USA

4. Janssen Scientific Affairs, LLC Horsham PA USA

5. Janssen Research & Development, LLC Spring House PA USA

6. SKiN Centre for Dermatology Peterborough ON Canada

7. Icahn School of Medicine at Mount Sinai New York NY USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16460

Reference19 articles.

1. Psoriasis: Which therapy for which patient

2. Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials

3. The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies

4. Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in A sia

5. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

2. Incidence of New-Onset Inflammatory Bowel Disease, Oral and Gastrointestinal Candidiasis, Herpes Zoster, Pulmonary Tuberculosis, and Major Cardiovascular Events in Patients with Moderate-to-Severe Psoriasis Exposed to Biologics;Journal of Clinical Medicine;2023-12-13

3. Safety of Biologics for Psoriatic Patients with Latent Tuberculosis;Clinical, Cosmetic and Investigational Dermatology;2023-08

4. Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study;Journal of Dermatological Treatment;2023-07-28

5. Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review;Advances in Therapy;2023-06-18